Trials / Unknown
UnknownNCT05710822
QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study
Very High-Power Short-duration Ablation Utilizing the QDOT Micro Ablation Catheter for Pulmonary Vein Isolation - A Multicenter Study.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- University of Luebeck · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
PeQasus is a worldwide, retrospective, multicenter analysis focusing on QDOT based PVI. Data of at least 300 patients with QDOT based PVI will be collected. All data will be evaluated after anonymization. Primary endoints are efficacy and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | pulmonary vein isolation | pulmonary vein isolation utilizing the QDOT Micro ablation catheter |
Timeline
- Start date
- 2023-01-31
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2023-02-02
- Last updated
- 2023-02-02
Source: ClinicalTrials.gov record NCT05710822. Inclusion in this directory is not an endorsement.